Clinical Features and Treatment of 2019-nCov Pneumonia Patients in Wuhan: Report of A Couple Cases

Virologica Sinica

Volumn 35, Issue 3, 2020, Pages 330-336

  Zhang, Zhan ^a   Li, Xiaochen ^a   Zhang, Wei ^b   Shi, Zheng Li ^b   Zheng, Zhishui ^a   Wang, Tao ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b WUHAN INSTITUTE OF VIROLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ARBIDOL; CHINESE DRUG; HUMAN IMMUNOGLOBULIN; METHYLPREDNISOLONE; MOXIFLOXACIN; OSELTAMIVIR; TANREQING; UNCLASSIFIED DRUG; RNA;

ADJUVANT THERAPY; ADULT; CASE REPORT; CHINA; CLINICAL ARTICLE; CLINICAL FEATURE; CORONAVIRUS DISEASE 2019; COUGHING; DISEASE COURSE; DYSPNEA; FEMALE; FEVER; HUMAN; IMMUNE RESPONSE; INFLUENZA A; LABORATORY TEST; LETTER; LUNG INFECTION; MALE; PNEUMONIA; RIGHT LUNG; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; THORAX RADIOGRAPHY; TREATMENT OUTCOME; X-RAY COMPUTED TOMOGRAPHY; BETACORONAVIRUS; CORONAVIRINAE; CORONAVIRUS INFECTION; IMMUNE EVASION; PANDEMIC; VIRUS PNEUMONIA;

BETACORONAVIRUS; CORONAVIRUS; CORONAVIRUS INFECTIONS; HUMANS; IMMUNE EVASION; PANDEMICS; PNEUMONIA, VIRAL; RNA;

EID: 85079239232     PISSN: 16740769     EISSN: 1995820X     Source Type: Journal    
DOI: 10.1007/s12250-020-00203-8     Document Type: Letter

References (9)

1. China Center for Disease Control and Prevention (China CDC) (2020) http://m.news.cctv.com/2020/01/09/ARTI9Vp9Lra4Tvltz3r7es96200109.shtml. Accessed 9 Jan 2020
2. Huang CB, Wang Q, Xie GQ, Liu AH, Lai B, Chen YJ, Cheng YJ, Xu H, Han DM (2004) Immunological characteristics of 1291 cases of severe acute respiratory syndrome in Beijing. Zhonghua Nei Ke Za Zhi 43:406–409 (in Chinese)
3. Kikkert M (2020) Innate immune evasion by human respiratory RNA viruses. J Innate Immun 12:4–20 DOI: 10.1159/000503030
4. National Health Commission of the People’s Republic of China (2007) National surveillance, investigation and management plan of unexplained pneumonia cases. 2007 (Code 158) http://www.nhc.gov.cn/bgt/pw10708/200708/4455f46a2f5e4908a8561c079ecbcf0e.shtml. Accessed 20 Jan 2020
5. Seillet C, Belz GT, Huntington ND (2016) Development, homeostasis, and heterogeneity of NK cells and ILC1. Curr Top Microbiol Immunol 395:37–61
6. Wang N, Li SY, Yang XL, Huang HM, Zhang YJ, Guo H, Luo CM, Miller M, Zhu GJ, Chmura AA, Emily E, Zhou JH, Zhang YZ, Wang LF, Daszak P, Zhi ZL (2018) Serological evidence of bat SARS-related coronavirus infection in humans, China. Virol Sin 33:104–107 DOI: 10.1007/s12250-018-0012-7
7. World Health Organization (WHO) (2020) Novel Coronavirus—China. https://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en/. Accessed 12 Jan 2020
8. Wuhan Municipal Health Commission (WMHC) (2020) http://wjw.wuhan.gov.cn/front/web/showDetail/2020012009077. Accessed 20 Jan 2020
9. Zhang J, Feng X, Liu S, Dai W, He Z, Dong Q, Song S, Liu Z, Yao J (2003) The study of B lymphocyte and NK cell in Severe Acute Respiratory Syndrome (SARS) patients. Chin J Immunol 19:378–380 (in Chinese)